Study of Additive Omega-3 Fish Oil to Palliative Chemotherapy to Treat Oesophagogastric Cancer

NCT01870791 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

21

Enrollment

OTHER

Sponsor class

Stopped Interim analysis

Conditions

Esophageal Neoplasm
Gastric Neoplasm

Interventions

DRUG: Omegaven

Sponsor

University Hospitals, Leicester